2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Carcinoma, Hepatocellular
44
Neoplasm Metastasis
19
Liver Neoplasms
18
Colorectal Neoplasms
15
Cholangiocarcinoma
11
Pancreatic Neoplasms
9
Lung Neoplasms
9
Colonic Neoplasms
9
Breast Neoplasms
8
Carcinoma, Renal Cell
7
Carcinoma, Non-Small-Cell Lung
7
Barrett Esophagus
7
Thyroid Nodule
6
Recurrence
6
Rectal Neoplasms
6
Thyroid Neoplasms
5
Pain
4
Neoplasms
4
Kidney Neoplasms
4
Esophageal Neoplasms
4
Thyroid Cancer, Papillary
3
Prostatic Neoplasms
3
Leiomyoma
3
Biliary Tract Neoplasms
3
Bile Duct Neoplasms
3
Agnosia
3
Thyroid Diseases
2
Hyperaldosteronism
2
Hepatitis B
2
Gallbladder Neoplasms
2
Interventions
Tamoxifen
4
Exercise
3
pyrotinib
2
abemaciclib
2
Paclitaxel
2
Metformin
2
Letrozole
2
Cyclophosphamide
2
Control Groups
2
Capecitabine
2
Bupivacaine
2
Aromatase Inhibitors
2
pembrolizumab
1
pegylated granulocyte colony-stimulating factor
1
pegfilgrastim
1
palbociclib
1
iniparib
1
exemestane
1
durvalumab
1
darolutamide
1
Yoga
1
Waiting Lists
1
Vitamin D
1
Tumor Burden
1
Tretinoin
1
Trastuzumab
1
Tocopherols
1
Thioctic Acid
1
Surveys and Questionnaires
1
Surgical Procedures, Operative
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Breast Cancer Female
×
Radiofrequency Ablation
×
Clear all
NCT04389216
2025-09-15
RFA
Hospital Universitari de Bellvitge
Phase NA
Completed
30 enrolled